Can Vet J 2020 06;61(6):621-628
Department of Veterinary Clinical Sciences, Faculty of Animal Science and Veterinary Medicine, Nong Lam University, Vietnam (Diep, Le Quang), Department of Clinical Sciences, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, Québec J2S 2M2 (Monteiro, Evangelista, Balleydier, Watanabe, Ruel, Doodnaught, Steagall).
This study evaluated the effects of ketamine-dexmedetomidine-midazolam as part of an opioid-free, multimodal protocol in cats undergoing ovariohysterectomy. In a prospective, blinded, randomized clinical trial, cats received either 1 of 2 doses of ketamine [5 mg/kg body weight (BW), = 10, K5 or 7 mg/kg BW, = 13, K7] with midazolam (0.25 mg/kg BW) and dexmedetomidine (40 μg/kg BW) intramuscularly, intraperitoneal bupivacaine (2 mg/kg BW) and subcutaneous meloxicam (0. Read More